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Transfection assays demonstrate that the varicella zoster virus (VZV) immediate-early 62 (IE62) protein is a major
transactivator of VZV gene expression, whereas a second immediate-early protein, IE4, can act as a major coactivator of
transactivation mediated through IE62. To test whether IE62 and IE4 interact physically, we performed several protein–
protein interaction assays. Coimmunoprecipitation analyses using VZV-infected cell lysates as well as purified protein
mixtures demonstrate that IE62 and IE4 form stable complexes in solution under stringent salt conditions. Enzyme-linked
immunosorbent assay protein–protein interaction assays and maltose-binding protein capture assays demonstrate that IE62
binds IE4 in a concentration- and dose-dependent manner. Far Western blot analyses show that IE4 binds to an undermodi-
fied form of IE62, and the use of calf intestinal phosphatase and protein kinases suggests that the interaction with IE4 is
dependent on the phosphorylation state of IE62. An IE4 binding domain on IE62 has been mapped using a set of truncated
IE62 fusion peptides. Collectively, these results imply a direct and specific physical interaction between IE4 and less-
phosphorylated forms of IE62. These data have implications for virion assembly, as well as for the regulation of gene
expression in VZV-infected cells. © 2000 Academic PressINTRODUCTION
Varicella-zoster virus (VZV) is the infectious agent of
chickenpox after primary infection and of shingles on
reactivation of latent virus.
The coordinate and timely regulation of gene expres-
sion is an integral feature of the replication of VZV. Thus
VZV genes contain complex regulatory regions with
unique core promoter sequences and binding sites,
which are targets for the combined controlling efforts of
cellular and viral factors (Kantakamalakul et al., 1995).
The IE62 gene regulatory protein is capable of transac-
tivation of all putative kinetic classes of VZV genes (In-
schauspe et al., 1989; Inschauspe and Ostrove, 1989;
Perera et al., 1992a; Baudoux et al., 1995) and of auto-
regulation of its promoter (Disney et al., 1990; Perera et
al., 1992b).
There are several mechanisms through which IE62
may be able to recognize and function at different pro-
moter elements; one is to alter promoter binding capacity
through interaction with other viral gene regulatory pro-
teins such as the products of open reading frames
(ORFs) 10, 61, 63, or 4 or with cellular proteins. Another
1 Present address: Roswell Park Cancer Institute, Elm and Carlton
treets, Buffalo, NY 14263.
2 To whom correspondence and reprint requests should be ad-
dressed. Department of Microbiology, 138 Farber Hall, SUNY at Buffalo
School of Medicine, Buffalo, NY 14214. Fax: (716) 829-2158. E-mail:
jhay@buffalo.edu.
375potential mechanism is through posttranslational modi-
fication, such as phosphorylation.
Several lines of evidence suggest that functional in-
teractions occur among VZV IE62, and IE4. First, IE62
and IE4 activate gene expression synergistically (In-
schauspe et al., 1989). Second, the intranuclear localiza-
tion of IE4 has been reported to be affected by the
presence of IE62 (Defechereux et al., 1996). Third, the
HSV ICP4 and ICP27 proteins (homologs to IE62 and IE4)
have been shown to interact functionally and physically
(Panagiotidis et al., 1997). Finally, the IE62 and IE4 pro-
teins are also both present in the VZ virion tegument,
suggesting the potential for their intervention at the ear-
liest stages of VZV replication (Kinchington et al., 1995).
In an attempt to clarify the molecular mechanisms
underlying the cooperative regulation of gene expression
mediated by IE62 and IE4, as well as their presence in
the virion tegument, we postulate that there is a direct
physical interaction between them, and we have used a
number of assay systems to demonstrate the interaction.
RESULTS
Given the ability of IE4 to assist IE62 in transactivation
of viral promoters, we propose that there is a physical
interaction between the two. Indirect evidence for this
has already been reported (Defechereux et al., 1996),
showing that in the presence of IE62, IE4 is targeted to
the cell nucleus. We used several assays to determine
the existence of a physical interaction between IE62 and
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376 SPENGLER, RUYECHAN, AND HAYIE4, and demonstrate that this physical interaction is
modified by protein kinase activity.
Coimmunoprecipitation of IE62 and IE4 using extracts
of VZV-infected cells and VZV proteins
synthesized in vitro
First, to determine whether these two proteins asso-
ciate with each other in VZV-infected cells, we coimmu-
noprecipitated IE62 and IE4 from a VZV-infected MeWo
cell lysate using a monoclonal antibody specific for IE62.
The presence of VZV proteins in the immunoprecipitates
was monitored by Western blot analyses. Clearly, in the
immune precipitate collected using the anti-IE62 anti-
body, there is evidence of the presence of IE4, implying
that IE62 and IE4 are associated in the infected cell (Fig.
1). The reverse experiment also was done, in which
anti-IE4 antibody was used to precipitate infected cell
extracts; in this case, IE62 was shown to be present in
the precipitate (Fig. 2). Interestingly, the species of IE62
associating with IE4 in this assay is a faster migrating
form.
To demonstrate a direct association between IE62 and
FIG. 1. Coimmunoprecipitation in vivo of VZV-infected cell extracts
with anti-IE62 antibody. MeWo cells were infected with VZV (Oka), and
cell lysates were clarified and then reacted with or without a monoclo-
nal antibody against IE62. Protein G–Sepharose was added to enhance
immune precipitation. Western analysis was performed on the immu-
noprecipitates after SDS–PAGE. The blot was divided into two sections:
section A was probed for IE62, and section B was probed for IE4. Each
section contains the same three lanes: lane 1, infected cell lysate,
protein G–Sepharose, and anti-IE62 antibody; lane 2, infected cell
lysate and anti-IE62 antibody; and lane 3, infected cell lysate.
FIG. 2. Coimmunoprecipitation in vivo of VZV-infected cell extracts
with anti-IE4 antibody. Cell extracts were made and reacted with
polyclonal antibody against IE4 as described for Fig. 1. The figure
shows a Western blot probed with anti-IE62 polyclonal antibody. Lane
1 is the VZV-infected cell lysate, lane 2 is infected cell lysate and
protein G–Sepharose, and lane 3 is infected cell lysate, anti-IE4 anti-
body, and protein G–Sepharose. On this gel, IE62 has been resolved
into two bands and IE4 seems to be associated with a faster-moving
form.IE4, purified proteins were coimmunoprecipitated in
vitro. IE62 protein was mixed with MBP4 or MBP, and
monoclonal anti-IE62 antibody and protein G–Sepharose
were added. The resulting immune precipitate contained
both VZV proteins, demonstrating their complex forma-
tion in solution (not shown). To investigate the strength of
this IE62–IE4 interaction, the salt sensitivity of the protein
complex was analyzed. IE62 and IE4 were coimmuno-
precipitated, as earlier, in solutions of increasing NaCl
concentration. As shown in Fig. 3, the protein complex
was stable in NaCl concentrations of up to 350 mM.
These data argue against a weak or nonspecific ionic
interaction. Note that the faster moving band in the left
lane (MBP alone) does not appear to be involved in
binding to IE62.
Having shown an interaction between IE62 and IE4 in
the infected cell and in solution, an enzyme-linked im-
munosorbent assay was used to characterize the inter-
action. Wells were coated with either MBP or MBP4, and
IE62 was added. The binding of IE62 was detected using
FIG. 4. Enzyme-linked immunosorbent assay of the IE62–IE4 inter-
action. The target proteins, MBP and MBP4, were bound to a 96-well
microtiter plate and reacted with IE62. Bound IE62 was assayed using
a monoclonal antibody against IE62 and a secondary antibody conju-
FIG. 3. Stability of the IE62–IE4 complex. Purified recombinant MBP4
and IE62 proteins were coimmunoprecipitated using a monoclonal
antibody against IE62 in various salt concentrations ranging from 70 to
1300 mM NaCl. Washed immune precipitates were resolved by SDS–
PAGE, followed by electroblotting onto nitrocellulose. A Western assay
was performed using an antibody against MBP.gated with horseradish peroxidase. Substrate color development was
assayed at 450 nm.
o
a
a
E
p
377VZV IE62-IE4 INTERACTIONSthe H6 anti-IE62 monoclonal antibody and a colorimetric
sandwich assay. No IE62 bound to wells with MBP alone,
but a saturable curve of binding to MBP4 was seen
(Fig. 4).
Mapping an IE4 binding site on IE62
To determine which region or regions of IE62 are
involved in interaction with IE4, we expressed various
sequences from IE62 in bacteria as GST fusion proteins.
Cleared bacterial lysates of each truncated fusion pro-
tein were resolved on SDS–PAGE and transferred to
PVDF membranes. A far Western assay was performed
using either MBP or MBP4 as the interacting protein.
Visualization of MBP4 binding was accomplished with an
antibody to MBP, followed by a conjugated second anti-
body for ECL detection. As demonstrated in Fig. 5, the
minimal IE62 N-terminal region that binds IE4 consists of
amino acids 1–299, whereas the sequence between
amino acids 1 and 161 fails to bind. Therefore, amino
FIG. 5. Mapping an IE4 binding site on IE62. (Top) Structures of IE62
deletions fused to the C-terminus of GST, along with their binding
capacity for IE4 (shown as 1 or 2). The IE62 deletions were resolved
n SDS–PAGE and electroblotted onto PVDF membranes. A far Western
ssay was then carried out using MBP4 as the interacting protein and
nti-MBP antibody as the detector. (Bottom) IE4 binding detected by
CL immunodetection (A). (B) Imido black-stained blot, detecting all
roteins.acids 161–299 in IE62 contain sequences important for
IE4 binding. This assay, however, does not rule out thepossibility that other sequences in IE62 may also be
involved in binding IE4.
IE4 binds to differently modified forms of IE62
Based on its primary sequence, IE62 has a calculated
molecular mass of 140 kDa, but migrates on SDS–PAGE
as a protein of 175 kDa. The basis for this, as with its
herpes simplex virus (HSV) relative, ICP4, is posttrans-
lational modification, including phosphorylation. It is rel-
atively straightforward to resolve IE62 on one-dimen-
sional SDS–PAGE into several components, thus allow-
ing an investigation into the binding of IE4 to different
modified forms of IE62. IE62 polypeptides were sepa-
rated by SDS–PAGE and electrotransferred to PVDF
membranes in Tris–glycine buffer. An ECL far Western
assay revealed the binding of MBP4 to faster migrating
species of IE62 (Fig. 6). These results suggest that IE4
preferentially binds to less posttranslationally modified
forms of IE62.
Interaction of IE4 with dephosphorylated IE62
In the above analysis, IE4 bound preferentially to less
than fully modified forms of IE62. IE62 is phosphorylated
(Roberts et al., 1985), and at least part of the explanation
for differential binding by IE4 may be the presence or
absence of phosphate groups. Thus IE62 was dephos-
phorylated with calf intestinal alkaline phosphatase, and
a far Western assay was performed, as above, with
MBP4. The results of this assay (Fig. 7) demonstrate that
FIG. 6. IE4 binds to a less-modified form of IE62. An insect cell lysate
containing IE62 was immunoprecipitated with anti-IE62 antibody, ana-
lyzed on SDS–PAGE, and electroblotted. GST62(1–406) was similarly
analyzed, as a positive control. A far Western assay was carried out
using MBP4 as interacting protein and anti-MBP antibody as the de-
tecting antibody (right). (left) Imido black-stained proteins. The arrow
points to the major imido black-stained IE62 polypeptide.
p378 SPENGLER, RUYECHAN, AND HAYIE4 is not binding to the most highly phosphorylated
forms of IE62 but to a less phosphorylated form or forms.
A Western blot was used to confirm that the faster mi-
grating bands were authentic IE62 polypeptides (not
shown).
Lack of interaction of IE4 with phosphorylated IE62
As a corollary to the previous experiment, GST62(1–
299), a truncation mutant that binds to IE4 (see earlier),
was treated with protein kinase C and protein kinase A in
separate experiments, before carrying out far Western
analyses with IE4. As anticipated (Figs. 8 and 9), phos-
phorylation of IE62 with either kinase removed the ability
of IE4 to bind to IE62, supporting the previous result that
IE4 binds to underphosphorylated IE62.
FIG. 7. IE4 binds to a less-phosphorylated form of IE62. IE62 purified
from insect cells was treated with or without calf intestinal phospha-
tase, resolved by SDS–PAGE, and electroblotted. Affinity for IE4 was
measured as before, using MBP4. (A) Imido black staining (B) Far
Western blot. The arrows indicate greater (top) and lesser (bottom)
phosphorylated forms of IE62.
FIG. 8. Protein kinase C treatment of IE62 alters IE4 binding activity.
by SDS–PAGE before blotting, imido black staining, autoradiography, o
incubated with 32P-ATP in the presence and absence of kinase, followed b
erformed on kinase-treated electroblotted proteins in the presence and absMapping a phosphorylated amino acid in IE62
involved in IE4 binding
Both protein kinase A and protein kinase C specifically
phosphorylate amino acids in the primary structure of a
protein based on consensus sequences. We examined
the sequence or sequences in IE62 involved in IE4 bind-
ing (161–299) for serine and threonine residues that may
be phosphorylated by the two kinases; Fig. 10 shows the
analyses. The one residue that is commonly modified by
both kinases is threonine 250; thus the phosphorylation
state of this amino acid appears to be a factor in the
ability of IE4 to bind to IE62.
DISCUSSION
We have demonstrated that the VZV gene regulatory
proteins IE62 and IE4 exist in the infected cell as a
1–299) was treated with protein kinase C. The proteins were analyzed
estern analysis with MBP4 and anti-MBP antibody. (A) Samples were
FIG. 9. Protein kinase A treatment of IE62 alters IE4 binding activity.
GST62(1–299) was treated with protein kinase A in the presence and
absence of ATP. Proteins were analyzed by SDS–PAGE before blotting,
staining with imido black, and far Western analysis using IE4 binding.GST62(
r far Wy autoradiography. (B) Far Western analysis using IE4 binding was
ence of ATP.
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379VZV IE62-IE4 INTERACTIONScomplex and that the two proteins can form a stable
interaction in vitro without the involvement of other pro-
eins. Whether the in vivo complex contains additional
iral or cellular proteins remains to be elucidated, but
ecause formation of multicomponent complexes is the
allmark of eukaryotic gene regulation, it would be sur-
rising if this were not the case. In recent experiments,
e have been able to demonstrate that two other VZV
roteins, IE63 and the ORF 9 product, can also be coim-
unoprecipitated by anti-IE62 antibody from infected cell
xtracts. The IE62–IE4 interaction appears to involve a
egion of the IE62 molecule that lies between the acidic
ctivation domain and the DNA-binding domain; we do
ot, however, rule out the involvement of other IE62
egions in IE4 binding.
Less-phosphorylated forms of IE62 appear to bind IE4
ore effectively than more-phosphorylated forms, and
hus phosphorylation seems to be involved in control of
he IE62–IE4 interaction. A potentially important residue
n this complex formation is threonine 250; a planned
xperiment is to mutate threonine 250 in viral variants
nd assess the role of this residue in the viral life cycle.
Because IE4 up-regulates the ability of IE62 to trans-
ctivate a variety of VZV promoters (Perera et al., 1992),
e assume that the physical interactions we have dem-
nstrated are involved in this process. Presumably, IE4
ids IE62 transactivation through mechanisms that
FIG. 10. Implicating IE62 threonine 250 in the IE4 interaction. The
equence of amino acids 161–299 of IE62, which we determined to be
mportant for the IE62–IE4 interaction, is shown in the upper part of the
igure. Potential sites for phosphorylation by protein kinase A and
rotein kinase C are listed in the lower half; the common site (T250) is
ircled.trengthen the interaction of IE62 with specific promoter
equences or with the preinitiation complex or through
H
gnteraction with cellular factors that can enhance tran-
cription. Interestingly, Michael et al. (1998) have shown
hat IE62 may also specifically interact with the IE4 pro-
oter, potentially controlling IE4 production.
Phosphorylation and dephosphorylation of proteins
re important control mechanisms of a variety of events
hat are crucial for growth and proliferation of cells. Many
f these biological processes are regulated at the tran-
criptional level, which in turn is controlled by protein
inases (Hunter and Karin, 1992). Our investigation sup-
orts the concept that the differently phosphorylated
orms of IE62 may play different roles in viral gene
egulation. Indeed, as we (unpublished observations)
nd others (Defechereux et al., 1996) have shown, IE4 is
ot always colocalized with IE62 in the VZV-infected cell,
nd it is quite possible that colocalization is also depen-
ent on phosphorylation. Analagous to HSV ICP4 (Mi-
hael et al., 1988) and to numerous transcription factors
Hunter and Karin, 1992), it may be that these phosphor-
lated forms vary in their ability to bind promoter se-
uences, resulting in differential viral gene expression. A
urther role for IE4 in binding to IE62 may be to “protect”
t from phosphorylation through its binding to unmodified
E62, indirectly affecting its regulatory activity. Xia et al.
1996a,b) have shown that HSV ICP4 can be phosphor-
lated by protein kinase A and protein kinase C. The
hief protein kinase A site or sites lie in a serine-rich
egion of ICP4, close to the N-terminus. There is an
nalogous serine-rich region in VZV IE62, but it is close
o the C-terminus (aa 1285–1295) and is different from the
hosphorylatable IE4-binding sequences described
ere.
Finally, as discussed earlier, both IE62 and IE4 are
ound in substantial amounts in the VZ virion tegument.
ur data show (Spengler et al., 2000) that although IE62
n the infected cell nucleus appears to be quite heavily
hosphorylated and does not interact with IE4, the IE62
n purified virus particles migrates on SDS–PAGE as a
ess-phosphorylated species and interacts readily with
E4. Thus in addition to a potential role for the IE62–IE4
nteraction in gene regulation, it is also possible that the
odification state of these proteins controls the assem-
ly (or disassembly or both) of virus particles in the
nfected cell.
MATERIALS AND METHODS
ells and viruses
MeWo cells, a human melanoma cell line that supports
he replication of VZV, were grown in Eagle’s minimal
ssential medium with 10% fetal bovine serum. VZV
train Scott or Oka was propagated by mixing trypsinized
ZV-infected cells with noninfected cells at a 1:4 ratio.
uman foreskin fibroblast (HFF) cells were also used to
enerate VZV-infected cell extracts.
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380 SPENGLER, RUYECHAN, AND HAYThe baculovirus Autographa californica nuclear poly-
edrosis virus (AcNPV) was grown in Spodoptera frugi-
erda (Sf21) cells as described in the Clontech (Palo Alto,
A) manual.
onstruction of a recombinant baculovirus-expressing
E62 protein and its purification
A pGem plasmid containing the VZV EcoRIJ fragment
containing VZV ORF 62) was digested with ScaI and
glII and transferred into the Clontech transfer vector,
hich was digested with SmaI and BglII. Cotransfection
f this transfer vector with Bac PAK 6 viral vector (Clon-
ech) generated the recombinant baculovirus Bac62. Sf21
nsect cells at 75% confluence were infected at an m.o.i.
f 10 with Bac62 and expressed IE62 protein abundantly
n day 2. This protein migrated on SDS–PAGE with VZV
E62 from VZV-infected HFF nuclear extracts and reacted
ith polyclonal and monoclonal anti-IE62 antibodies. To
urify IE62, nuclear extracts of the insect cells were
repared as described by Lee et al. (1988). This extract
as applied to a Pharmacia (Piscataway, NJ) Q Sepha-
ose column, and fractions eluted with increasing NaCl
oncentrations; IE62 eluted with a peak at 400 mM. This
eak fraction was then applied to an Sp Sepharose
olumn and eluted at 300 mM NaCl. PAGE analyses and
ensitometry showed that this preparation of IE62 was
pproximately 90% pure.
ntibodies
Polyclonal antibodies to VZV IE4 were generously sup-
lied by Dr. P. R. Kinchington (University of Pittsburgh).
onoclonal antibody to IE62 (H6) was purified from hy-
ridoma cells (a gift of Dr. Ann Arvin, Stanford University),
sing the Pharmacia EZ Sep kit. Polyclonal antibodies to
E62 were made by resolving the chromatographically
urified IE62 on 7% SDS–PAGE, excising 100 mg of the
175-kDa band, and emulsifying it in complete Freund’s
adjuvant for injection into rabbits. A histidine-tagged IE62
fusion protein containing the IE62 N-terminal 735 amino
acids was purified over a nickel column (His Bind metal
chelation resin; Novagen, Madison, WI) and similarly
resolved and excised from an SDS–polyacrylamide gel.
This was also injected into rabbits. An initial inoculation
and two booster doses were sufficient to give high titers,
as determined by enzyme immunoassay.
Construction of fusion proteins and their purification
To express the IE62 ORF as a fusion protein at the
C-terminus of glutathione-S-transferase (GST), a two-
step process was used. The Clontech transfer vector
containing IE62 (used to construct the Bac62; see earlier)
was digested with BamHI and BglII liberating IE62 C-
terminal (2.8-kb) sequences; this was ligated into pGEX
(Pharmacia), which was digested with BamHI, to give
t
spGEX62 (C-terminal 2.8 kb). Next, a pET 28a vector (No-
vagen) with the IE62 N-terminal 2.2-kb sequence was
digested with BamHI, liberating a 2.2-kb fragment to be
ligated into pGEX62, which was digested with BamHI.
The result was full-length IE62 in pGEX.
Truncated GST62 fusion proteins were constructed as
follows. GST62 (1–735 aa) was generated by inserting
the 2.2-kb N-terminus of the IE62 gene into pGEX di-
gested with BamHI. GST62 (1–406 aa), GST62 (1–299 aa),
GST62 (1–161 aa), and GST62 (1–43 aa) were generated
from pGEX62 (2.2 kb) using digestion with the following
restriction enzymes: SalI, StyI, SphI, StuI, and XhoI, re-
spectively. For growth, plasmids were transfected into
DH5a cells by electroporation. Fusion proteins were ex-
pressed after isopropyl-b-D-thiogalactopyranoside (IPTG)
nduction from cultures of the transfected Escherichia
oli. Extracts were prepared in PBS buffer and purified
ver glutathione–Sepharose 4B (Pharmacia Biotech).
To express IE4 as a fusion protein at the C-terminus of
he maltose-binding protein (MBP), the entire ORF 4 was
xcised from pGEX4 digested with BamHI and ligated
nto pMalc2 (New England Biolabs, Beverly, MA) di-
ested with BamHI. Transfection and induction were
onducted as above. The plasmid pGEX4 had been
ade by digestion of the cosmid pVFsp4 (a gift of Dr. G.
emble, Aviron Inc.) with EcoRI. The largest fragment (14
b) was digested with NcoI, and a 4-kb fragment was
urther digested with SalI after blunting with Klenow
ragments (GIBCO BRL, Grand Island, NY). The final fu-
ion fragment was digested with SmaI and SalI. Cell
xtracts carrying MBP4 were prepared in cell lysis (C)
uffer (20 mM Tris–HCl, pH 7.4, 0.2 M NaCl, 1 mM EDTA).
rotein purification was accomplished using amylose
esin (New England Biolabs).
All DNA constructions were verified using restriction
nzyme digestion, and all fusion proteins were analyzed
y PAGE for purity and by Western blotting for specificity.
oimmunoprecipitation assays
VZV-infected MeWo cells were harvested at 80% CPE
nd lysed in PBS by passage through a 25-gauge needle.
leared lysates were mixed with anti-IE4 or anti-IE62
ntibodies and protein G–Sepharose (Pharmacia) to fa-
ilitate immunoprecipitation. After mixing for 4 h at 4°C,
mmunoprecipitates were spun and washed three times
n PBS with 0.1% Tween 80. Pellets were boiled in sample
uffer and resolved on SDS–PAGE, followed by transfer
o nitrocellulose. ECL Western analyses were performed
n the blots. Similarly, purified recombinant proteins
from various constructs expressing IE62 or IE4) were
dded to PBS with 2% BSA and 0.1% Tween 80. Either
nti-MBP or anti-IE62 antibodies were added with pro-ein G–Sepharose as described, and material was re-
olved on SDS–PAGE followed by Western blotting.
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381VZV IE62-IE4 INTERACTIONSEnzyme-linked immunosorbent assay
Target protein (500 ng), either MBP or MBP4, was
bound overnight at 4°C onto 96-well plates and blocked
for 2 h with 2% BSA before being reacted with IE62
protein for 1 h. After extensive washing, target proteins
were reacted with the monoclonal antibody to IE62 for
1 h. After more extensive washing, a secondary antibody
to mouse IgG conjugated with horseradish peroxidase
was allowed to react for 1 h. After a final washing, the
colorimetric substrate TMB was added, and plates were
read at 450 nm after a 20-min reaction.
MBP fusion protein capture assays
Bacterial cell lysates expressing MBP and MBP4 were
induced for 2 h with IPTG and harvested. Cell pellets
were resuspended in lysis buffer, lysed by ultrasonic
treatment, and centrifuged at 14,000 rpm for 20 min.
Cleared lysates were applied to 50 ml of amylose resin
nd allowed to bind for 1 h at 4°C with gentle mixing.
ound resin was washed in lysis buffer and reacted with
E62 protein, which was diluted in lysis buffer with 2%
SA. After 1 h of gentle mixing, the resin was washed
xtensively, and pellets were boiled in sample buffer and
esolved on SDS–PAGE. IE62 protein was detected by
estern blotting, as discussed earlier.
ar western blots
Proteins were resolved on SDS–PAGE, electrophoreti-
ally transferred to Western PVDF membrane (Schleicher
Schuell, Keene, NH), and gradually renatured for 24 h
n HEPES buffer (20 mM HEPES, pH 7, 50 mM NaCl, 5
M MgCl2, 1 mM EDTA, 1 mM DTT, and 10% glycerol)
with incubation at 4°C overnight in the presence of 5%
nonfat dry milk. This buffer was then replaced with the
probing proteins in a 2% BSA–PBS solution. After 1 h,
blots were washed in PBS and reacted with anti-MBP
antibody for 1 h, followed by 1 h with a donkey anti-rabbit
antibody conjugated to horseradish peroxidase (Amer-
sham, Arlington Heights, IL). Purified IE62 was dialyzed
in 50 mM Tris–HCl, pH 8.5, and 0.1 mM EDTA at 4°C
overnight. The dialysate was divided in two, with one half
receiving 0.5 ml of calf intestinal alkaline phosphatase
(CIP) (26 U/ml; GIBCO BRL) and both incubated at 30°C
for 30 min. These samples were then boiled in SDS
buffer before SDS–PAGE analysis.
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